{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:36:08Z","timestamp":1789014968908,"version":"build-2803163510"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,1,1]]},"DOI":"10.2169\/internalmedicine.3202-23","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T22:14:22Z","timestamp":1715811262000},"page":"147-151","source":"Crossref","is-referenced-by-count":1,"title":["Neuropsychiatric Systemic Lupus Erythematosus in a Patient with Pancytopenia and Chronic Schizophrenia Requiring Hospitalisation"],"prefix":"10.2169","volume":"64","author":[{"given":"Taro","family":"Horino","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Inotani","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Komori","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Kochi Medical School, Kochi University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Haematology and Respiratory Medicine, Kochi Medical School, Kochi University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Aringer M, Costenbader K, Daikh D. European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78: 1151-1159, 2019."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol 10: 338-347, 2014.","DOI":"10.1038\/nrrheum.2014.15"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. van Dam AP, Wekking EM, Callewaert JA, et al. Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol Int 14: 57-62, 1994.","DOI":"10.1007\/BF00300248"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Stock AD, Wen J, Doerner J, et al. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL\/lpr mice. J Neuroinflammation 12: 205, 2015.","DOI":"10.1186\/s12974-015-0423-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mack A, Pfeiffer C, Schneider EM, et al. Schizophrenia or atypical lupus erythematosus with predominant psychiatric manifestations over 25 years: case analysis and review. Front Psychiatry 8: 131, 2017.","DOI":"10.3389\/fpsyt.2017.00131"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Benros ME, Nielsen PR, Nordentoft M, et al. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 168: 1303-1310, 2011.","DOI":"10.1176\/appi.ajp.2011.11030516"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chen YM, Chen HK, Wu BJ, et al. Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia. Schizophr Res 237: 166-173, 2021.","DOI":"10.1016\/j.schres.2021.08.032"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 64: 620-625, 2005.","DOI":"10.1136\/ard.2004.025528"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bertsias GK, Ioannidis JPA, Aringer M. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69: 2074-2082, 2010.","DOI":"10.1136\/ard.2010.130476"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nikolopoulos D, Fanouriakis A, Boumpas DT. Cerebrovascular events in systemic lupus erythematosus: diagnosis and management. Mediterr J Rheumatol 30: 7-15, 2019.","DOI":"10.31138\/mjr.30.1.7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82: 299-308, 2003.","DOI":"10.1097\/01.md.0000091181.93122.55"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/1\/64_3202-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T03:23:41Z","timestamp":1735961021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/1\/64_3202-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3202-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"3202-23"}}